Final results from the RA-BEYOND study show that patients with rheumatoid arthritis can often maintain disease control after tapering baricitinib from 4 mg to 2 mg.

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

Low-dose doxycycline proved to be equally as effective as high-dose doxycycline for the treatment of scarring alopecia, with ...

The Phase III API-CAT trial found that extended anticoagulant therapy with reduced-dose Eliquis (apixaban) was noninferior to ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

API-CAT establishes reduced-dose apixaban "as an appropriate regimen" for anticoagulation ... Before randomization, over half of the patients (55%) had been on low-molecular-weight heparin, and 44% ...

the low dose of apixaban was very effective at reducing the risk," she said. It is important to treat VTE as a chronic condition, said Joshua Beckman, MD, from the University of Texas Southwestern ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least ...

API-CAT was designed to test whether a lower dose of apixaban could continue to be protective while ... It’s very important that now we have data to support the continuous low dose.” API-CAT ...

followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication ...